It was shown that SIPA1 overexpression could enhance breast cancer stemness, alter breast cancer metabolism, and enhance breast cancer drug resistance, thereby promoting breast cancer progression [23, 24, 26, 28]. The gene discussed is SIPA1; the disease is breast carcinoma.